The -124C>T Mutation of the TERT Promoter Indicates Favorable Prognosis in Ovarian Clear Cell Carcinoma: A Single Institutional Study in China
Current Oncology · 2025
DOI: 10.3390/curroncol32080422 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, 2025. Verfasst von Xiaonan Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong'an Roa…. Hauptthemen laut MEDLINE: Telomerase, Ovarian Neoplasms, Promoter Regions, Genetic, Adenocarcinoma, Clear Cell. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Foundation Science of China.
Abstract (Originalsprache)
Background
Ovarian clear cell carcinoma (OCCC) is characterized by chemoresistance and poor prognosis in advanced or recurrent cases. This study aimed to find specific prognostic markers for OCCC.
Methods
We analyzed 169 OCCC patients for clinicopathological features. TERT promoter and PIK3CA mutations were assessed by Sanger sequencing, and immunohistochemistry for ARID1A, HDAC6, Cyclin E1, and p53 was performed on tissue microarrays. Survival analysis was conducted using Kaplan–Meier and Cox regression models.
Results
The -124C>T TERT promoter mutation was associated with longer OS and PFS and was an independent predictor of favorable OS. This mutation correlated with lower CA125 levels and higher SNP frequency. p53 mutations indicated advanced disease, bilateral tumors, reduced Cyclin E1, and poor prognosis. Low HDAC6 expression was linked to worse PFS. Mutual exclusivity was observed between PIK3CA exon 20 mutations and SNPs.
Conclusions
The -124C>T TERT promoter mutation may serve as a favorable prognostic marker in OCCC, while p53 mutations and reduced HDAC6 expression are associated with poor outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, 270 Dong'an Road, Shanghai 200032, China.
Förderung
- National Natural Foundation Science of China
Zitieren
APA
Zhou, X., Liu, Y., Hu, J., Zhang, J., Ren, M., Ji, G., Cai, X., & Bi, R. (2025). The -124C>T Mutation of the TERT Promoter Indicates Favorable Prognosis in Ovarian Clear Cell Carcinoma: A Single Institutional Study in China. Current Oncology. https://doi.org/10.3390/curroncol32080422
Vancouver
Zhou X, Liu Y, Hu J, Zhang J, Ren M, Ji G, et al. The -124C>T Mutation of the TERT Promoter Indicates Favorable Prognosis in Ovarian Clear Cell Carcinoma: A Single Institutional Study in China. Current Oncology. 2025. doi:10.3390/curroncol32080422
BibTeX
@article{Zhou2025,
author = {Zhou, Xiaonan and Liu, Yifei and Hu, Jue and Zhang, Jing and Ren, Min and Ji, Gang and Cai, Xu and Bi, Rui},
title = {The -124C>T Mutation of the TERT Promoter Indicates Favorable Prognosis in Ovarian Clear Cell Carcinoma: A Single Institutional Study in China},
journal = {Current Oncology},
year = {2025},
doi = {10.3390/curroncol32080422}
}
EUVIMED